30 closest matches · ranked by relevance
Focus Groups
Primary: Qualitative Analysis of Focus Group Audio-recording Transcripts. Open Coding Using Content Analysis Framework Will be Utilized to Assess Positive Regard for the…
Depression, Unipolar · Mental Health Disorder
Primary: Change in Clinically Significant Depressive Symptoms (MADRS) — 21.21; 21; 18.5; 15.77 score on a scale — p=0.31
Breast Cancer
Primary: Scores on the Personal Resource Questionnaire 85. — 50.22; 53.44 Scores on a scale — p=.315
Adherence, Medication · Transplantation, Kidney
Primary: Number of Kidney Transplant Patients Who Expressed an Understanding of the Term Immunosuppression Medication Adherence and the Importance Immunosuppression Medication…
Postpartum Depression · Postpartum Anxiety
Primary: Satisfaction as Assessed by the Intervention Satisfaction Survey — 4.06 score on a scale
Social Isolation · Depression
Primary: Change in Depression — -2.01; -5.10 units on a scale — p=0.0473
Mental Disorders
Primary: Patient Activation — 29.12; 28.82; 29.21 units on a scale
Drink Too Much · Drinking, Binge · Drunk
Primary: Number of Safety Actions Taken to Intervene Within Group — 2.14; 1.90 score on a scale — p=<0.001
Smokeless Tobacco Cessation
Primary: Number of First Responders Recruited Who Completed a Screening Assessment — 163 Participants
Advance Care Planning · Primary Health Care
Primary: Presence of Medical Decision-maker Documentation in the EHR — 41; 38; 51; 40 participants
Health Communication
Primary: Association Between Mean CD4 Count at Baseline and 3-month Visit — 385.86; 373.69 cells/mm^3 — p=0.859
HPV Vaccine Acceptability
Primary: Change From Baseline to Post Intervention to Follow-up (up to 3 Months) After the Interventions the Number of Participants Who Have Taken the HPV Vaccine — 0; 0; 0; 0…
Paranoia · Schizophrenia-spectrum Diagnosis
Primary: Green Paranoid Thoughts Scale (GPTS) — 109.77; 114.6; 84.8; 82.6 score on a scale
Type1 Diabetes
Primary: Number of Participants That Completed Interviews About Consultation Summaries They Were Receiving — 9 Participants
Mild Cognitive Impairment
Primary: Change in Readiness to Engage in ACP (ACP Engagement Scale) — 1.92; 1.54; 2.77; 2.00 units on a scale
Contraception
Primary: Number of Participants Reporting IUC Use — 2; 4 Participants — p=0.89
Type 2 Diabetes
Primary: Recruitment Group Preference — 54 participants
Collaboration Attitudes and Behavior
Primary: MATRICx Collaboration Benefits/Motivators Scale — 3.41; 3.48; 3.29; 3.31 Score on a scale
Suicide · Accidental Injuries · Firearm Injury
Primary: Feasibility of the Intervention — 18; 40 Participants
Smoking Cessation
Primary: The Number of Participants Reporting 7 Day Point Prevalence Abstinence — 54; 45 Participants
Alcohol-Related Disorders · Substance-Related Disorders
Primary: Change in Mean Days of Any Substance Use for Women — -3.93; -1.74; -4.45; 0.60 Days of any substance use per month — p=<0.05
Opioid-Related Disorders
Primary: Number of Participants With Opioid Abstinence at 8 Weeks — 0; 1 Participants — p=0.44
Dementia
Primary: Revised Memory and Behavior Problems Checklist (Reaction Subscale) — 19.46; 14.31; 10.73 score on a scale — p=<0.001
Mental Health Wellness 1 · Sexual Orientation · Gender Identity
Primary: Patient Health Questionnaire (PHQ-9) — 14.29; 11.50 score on a scale
Drug Abuse
Primary: Days of Stimulant Use — 2.35; 2.13 days of stimulant use — p=<0.05
Health Communication
Primary: Mean CD4 Count — 321.5; 418; 390.5 Cells/mm^3 — p=0.283
Anxiety Depression
Primary: Engagement (8-item Scale) — 3.90; 4.62 Mean engagement score
Cancer of Colon · Cancer of Rectum
Primary: Count of Products That Contain Red Meat — 3.5; 3.2; 3.1; 2.7 red meat products — p=0.002
Anxiety · Depression · Adolescent Behavior
Primary: Feasibility - IP Use Proportion — 0.10; 0.11; 0.10; 0.08 average proportion
Acute Coronary Syndrome · Depression · Myocardial Infarction
Primary: Number of Participants Reporting Changes After ACS — 3; 3; 10; 1 participants